Neuroversion Revenue

Medical Practices • Anchorage, Alaska, United States • 21-50 Employees

Neuroversion revenue & valuation

Annual revenue	$2,053,320
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Medical Practices industry and current estimated revenues	$6,600,000
Total funding	No funding

Key Contact at Neuroversion

Luke Liu

Chief Executive Officer

Company overview

Headquarters	2925 Debarr Road, Suite 240, Anchorage, Alaska 99508, US
Phone number	+19073394650
Websites	neuroversion.com neuroversion.net
NAICS	62
SIC	801
Keywords	Massage Therapy, Manual Therapy, Chronic Pain Management, Interventional Pain Management, Medication Management, Medication Assisted Therapy
Founded	2016
Employees	21-50
Socials

Neuroversion Email Formats

Neuroversion uses 1 email format. The most common is {first initial} (e.g., j@neuroversion.com), used 100% of the time.

Format	Example	Percentage
{first initial}	j@neuroversion.com	100%

About Neuroversion

NEUROVERSION is a medical practice company based out of 2925 DEBARR RD, Anchorage, Alaska, United States.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Manager

Employees by Department

Neuroversion has 12 employees across 3 departments.

Departments

Number of employees

Funding Data

Neuroversion has never raised funding before.

Neuroversion Tech Stack

Discover the technologies and tools that power Neuroversion's digital infrastructure, from frameworks to analytics platforms.

Google Workspace

Lodash

JavaScript libraries

Sentry

Issue trackers

Sirvoy

Appointment scheduling

Wix

Blogs

HTTP/3

Miscellaneous

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Cloud

IaaS

Google Cloud CDN

CDN

Envoy

Reverse proxies

Frequently asked questions

Neuroversion is located in Anchorage, Alaska, US.

You can reach Neuroversion at +19073394650.

Neuroversion generates an estimated annual revenue of $2,053,320. This revenue figure reflects the company's market position and business performance in its industry.

Neuroversion has an estimated valuation of $6,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Neuroversion was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Neuroversion has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Neuroversion

Luke Liu

Chief Executive Officer

4.8

40,000 users